Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-26T09:36:05.206Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychic and Somatic Reactions to Subconvulsive and Convulsive Doses of Triazol

Published online by Cambridge University Press:  08 February 2018

John B. Dynes  and
Henry Tod
John B. Dynes
Affiliation:
Harvard University (Moseley and Whitman Fellowships)
Henry Tod
Affiliation:
Royal Edinburgh Hospital (University of Edinburgh)
Get access Rights & Permissions [Opens in a new window]

Extract

This investigation attempts to determine what effect a sub-convulsive dose of triazol had on the individual patient as compared with a convulsive dose, and in addition to study and compare the reactions of a group of deteriorated schizophrenic patients with those of a heterogeneous group composed of mental disorders not schizophrenic. There were 12 patients in each group. The first group of schizophrenic patients was made up of individuals who showed marked emotional deterioration, with either a poverty of affective response or a definitely inappropriate affect. All these patients had had their mental disorder for many years. The average duration of the psychosis in the schizophrenic group was 9 years, and the average age of the group was 31 years. The heterogeneous group was composed of three patients classified as manic-depressive in the depressed phase, two depressed patients in a stuporous condition, three psychoneurotic patients with chronic anxiety states, and four with chronic obsessive states. The average age of the heterogeneous group was 33 years.

Type
Part II.—Original Articles
Information
Journal of Mental Science , Volume 85 , Issue 357 , July 1939 , pp. 796 - 802
Copyright
Copyright © Royal College of Psychiatrists, 1939 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Schilder, Paul.—Journ. Nerv. and Ment. Dis., 1939, lxxxix, pp. 133–144.CrossRefGoogle Scholar
2 Walk, A., and Mayer-Gross, W.—Journ. Ment. Sci., 1938, lxxxiv, p. 637.CrossRefGoogle Scholar
3 Tod, H.—Biochem. Journ., 1935, xxix, p. 914.CrossRefGoogle Scholar
4 Hall, G. E.—Amer. Journ. Psychiat., 1938, xcv, pp. 553, 566.CrossRefGoogle Scholar
5 Cannon, W. B.—Amer. Journ. Med. Sci., 1935, clxxxix, pp. 1–14.Google Scholar
6 Hoskins, R. G., and Sleeper, F. H.—Arch. Neur. and Psychiat., 1933, xxx, pp. 123–140.CrossRefGoogle Scholar
7 Jones, M. S., and Tod, H.—Biochem. Journ., 1935, xxix, p. 2242.CrossRefGoogle Scholar
8 Tod, H., and Jones, M. S.—Edin. Med. Journ., 1937, xliv, p. 46.Google Scholar
9 Stalker, H., Millar, W. M., and Jacobs, J. M.—Lancet, 1939, i, p. 437.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.